Tsh Biopharmoration Valuation
| 8432 Stock | TWD 61.00 0.30 0.49% |
At this time, the company appears to be fairly valued. tsh biopharmoration has a current Real Value of NT$61.58 per share. The regular price of the company is NT$61.0. Our model measures the value of tsh biopharmoration from inspecting the company fundamentals such as Shares Outstanding of 38.4 M, operating margin of 0.16 %, and Return On Equity of 0.0635 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Tsh Biopharmoration's price fluctuation is very steady at this time. Calculation of the real value of tsh biopharmoration is based on 3 months time horizon. Increasing Tsh Biopharmoration's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Tsh stock is determined by what a typical buyer is willing to pay for full or partial control of tsh biopharmoration. Since Tsh Biopharmoration is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tsh Stock. However, Tsh Biopharmoration's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 61.0 | Real 61.58 | Hype 61.0 |
The intrinsic value of Tsh Biopharmoration's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tsh Biopharmoration's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of tsh biopharmoration helps investors to forecast how Tsh stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tsh Biopharmoration more accurately as focusing exclusively on Tsh Biopharmoration's fundamentals will not take into account other important factors: Tsh Biopharmoration Total Value Analysis
tsh biopharmoration is presently anticipated to have takeover price of 1.17 B with market capitalization of 1.78 B, debt of 7.01 M, and cash on hands of 708.28 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Tsh Biopharmoration fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.17 B | 1.78 B | 7.01 M | 708.28 M |
Tsh Biopharmoration Investor Information
About 65.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.77. In the past many companies with similar price-to-book ratios have beat the market. tsh biopharmoration last dividend was issued on the 13th of June 2022. The entity had 1:1 split on the 28th of August 2013. Based on the analysis of Tsh Biopharmoration's profitability, liquidity, and operating efficiency, tsh biopharmoration is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Tsh Biopharmoration Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tsh Biopharmoration has an asset utilization ratio of 35.36 percent. This indicates that the Company is making NT$0.35 for each dollar of assets. An increasing asset utilization means that tsh biopharmoration is more efficient with each dollar of assets it utilizes for everyday operations.Tsh Biopharmoration Ownership Allocation
tsh biopharmoration shows a total of 38.4 Million outstanding shares. tsh biopharmoration has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.94 % of Tsh Biopharmoration outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tsh Biopharmoration Profitability Analysis
The company reported the revenue of 413.48 M. Net Income was 47.11 M with profit before overhead, payroll, taxes, and interest of 247.36 M.About Tsh Biopharmoration Valuation
Our relative valuation model uses a comparative analysis of Tsh Biopharmoration. We calculate exposure to Tsh Biopharmoration's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tsh Biopharmoration's related companies.TSH Biopharm Corporation Limited develops, manufactures, and markets drugs for various chronic diseases in Taiwan and China. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited. TSH BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.
8 Steps to conduct Tsh Biopharmoration's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tsh Biopharmoration's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tsh Biopharmoration's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tsh Biopharmoration's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tsh Biopharmoration's revenue streams: Identify Tsh Biopharmoration's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tsh Biopharmoration's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tsh Biopharmoration's growth potential: Evaluate Tsh Biopharmoration's management, business model, and growth potential.
- Determine Tsh Biopharmoration's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tsh Biopharmoration's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Tsh Stock Analysis
When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.